A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

Leyland-Jones B, Bondarenko I, Nemsadze G, Smirnov V, Litvin I, Kokhreidze I, Abshilava L, Janjalia M, Lakshmaiah KC, Tarasova O, Mohapatra RK, Sparyk Y, Polenkov S, Vladimirov V

https://www.ncbi.nlm.nih.gov/pubmed/26858335

J Clin Oncol. 2016 Apr 10;34(11):1197-207. doi: 10.1200/JCO.2015.63.5649. Epub 2016 Feb 8

PMID:26858335DOI:10.1200/JCO.2015.63.5649

EXTENSION CLINIC
+63-2-8521-0020 / +63-2-8521-8647

GLOBAL CITY
+63-2-8789-7700

QUEZON CITY
+63-2-8723-0101

A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

GET IN TOUCH

EXTENSION CLINIC+63-2-8521-0020 / +63-2-8521-8647

GLOBAL CITY+63-2-8789-7700

QUEZON CITY+63-2-8723-0101

A Randomized, Open-Label, Multicenter, Phase III Study of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

EXTENSION CLINIC
+63-2-8521-0020 / +63-2-8521-8647

GLOBAL CITY
+63-2-8789-7700

QUEZON CITY
+63-2-8723-0101